Skip to main content
. 2020 Jun 11;10(8):e01701. doi: 10.1002/brb3.1701

FIGURE 3.

FIGURE 3

Network meta‐analysis of efficacy and acceptability of CGRP antagonists for migraine. The odds ratios (ORs) of comparisons of drugs are between the column‐defining drug and the row‐defining drug. Regarding efficacy, ORs higher than 1 favors the column‐defining drug. Regarding acceptability, ORs lower than 1 favors the column‐defining drug